The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Pharmacy-based Arthritis Screening Debuts in Canada

Pharmacy-based Arthritis Screening Debuts in Canada

February 1, 2014 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Pharmacists Raise Level of Care for Patients with Knee Osteoarthritis
  • Better Blood Pressure Screening Needed to Manage Cardiovascular Disease Risk in Rheumatoid Arthritis
  • Knee Replacement Offers Cardiovascular Benefits for Patients with Arthritis
Explore This Issue
February 2014
Also By This Author
  • Website Devoted to Arthritis Self-Management
Pharmacy-based Arthritis Screening Debuts in Canada

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Last fall, the Canadian Ministry of Health and the Shoppers Drug Mart/Pharmaprix chain of 1,200 pharmacies announced the launch of their Arthritis Screening Program. The program uses pharmacists to help screen for osteoarthritis of the knee (KOA) and to give information on treatments as well as medications. It is the result of research carried out by the Arthritis Research Centre of Canada (ARC) under the auspices of the Canadian Institute of Health Research.

“It has been long established in diabetes and other diseases that pharmacists are in a position to detect problems early, largely because they see patients eight times more often than the family doctor,” says John Esdaile, MD, scientific director for the center. “We wanted to know if pharmacists were a way of detecting KOA earlier than we do now.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Two Studies

The center completed two studies on the subject as a precursor to the screening program. The first was a pilot study published in 2007.1 The second was a randomized controlled trial that looked at interventions after the pharmacist had completed the screening.2

“In the first study, we basically administered a questionnaire to people 50 years and older who had pain in or around the knee,” says Carlo A. Marra, PharmD, PhD, from ARC and the faculty of Pharmaceutical Sciences at the University of British Columbia in Vancouver. “The pharmacists did a really good job of finding people with KOA who hadn’t been diagnosed before. The care gap appeared to be massive.”

For the follow-up study, the patients were first screened. Seventy-three patients suspected of having arthritis were randomized to the treatment arm. Their current medication regimens were reviewed, and they received suggestions for over-the-counter medication and treatment following the 2008 ACR guidelines. They were also referred to a physiotherapist (PT) for guidance on exercise and weight control. The 66-person control group was given a pamphlet on KOA.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“We found highly significant changes in the pass rate on the Arthritis Foundation’s quality indicators for OA among those receiving treatment,” notes Dr. Esdaile. “In addition, there were significant differences in pain, movement, and function scores on various tools at three and six months. Another look at the data showed this to also be very cost effective, driven by lower medicine costs from the pharmacist consultation as well as fewer visits to physician apparently tied to the use of PTs.”

Pharmacist-Centered Program Useful

The results indicated that pharmacist-centered interventions could be useful in both finding and treating KOA. This led to the wider program currently underway by the Shoppers Drug Mart chain.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Drug Updates, Osteoarthritis, Pharma Co. News, Research Reviews, Rheumatoid Arthritis Tagged With: Arthritis Screening, Canada, International, knee osteoarthritis, Ministry of Health, Osteoarthritis, pharmacy, Rheumatoid arthritis, rheumatologistIssue: February 2014

You Might Also Like:
  • Pharmacists Raise Level of Care for Patients with Knee Osteoarthritis
  • Better Blood Pressure Screening Needed to Manage Cardiovascular Disease Risk in Rheumatoid Arthritis
  • Knee Replacement Offers Cardiovascular Benefits for Patients with Arthritis
  • Chronic Osteoarthritis Management Initiative Calls for Better OA Screening, Treatment

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)